Open research questions in Hemoglobinopathies and Related Disorders
258 gap statements mined from Hemoglobinopathies and Related Disorders papers in our 4.5M-paper local library, which holds 1,551 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Hemoglobinopathies and Related Disorders? See the ranked Medicine journals.
What the literature leaves open
There is a need to identify parameters associated with adverse outcomes in sickle cell disease. There is a need to evaluate the clinical profile of adult patients with sickle cell disease.
Clinical Characteristics and Outcome Predictors in Adult Patients with Sickle Cell Disease: A Prospective Observational Study · 2026 · DOILarger multicentric studies are needed that sample a greater diversity of the population to better understand the range and outcomes of individuals with SCD within India.
Clinical Characteristics and Outcome Predictors in Adult Patients with Sickle Cell Disease: A Prospective Observational Study · 2026 · DOIThe study has a limited sample size. The study only includes adults with SCD who underwent HSCT. The study does not investigate the effect of HSCT on cognitive function.
Hematopoietic Stem Cell Transplant and Brain Volume Changes in Adults With Sickle Cell Disease · 2026 · DOIThe effect of HSCT on brain volume changes in adults with SCD is unknown. There is a lack of longitudinal studies investigating the association between HSCT success and brain volume changes in SCD patients.
Hematopoietic Stem Cell Transplant and Brain Volume Changes in Adults With Sickle Cell Disease · 2026 · DOIVitamin D deficiency is a significant global health concern. Patients with SCD are disproportionately affected by vitamin D deficiency. There is a need to identify potential markers for vitamin D deficiency in SCD patients.
Association Between Neutrophil-to-Lymphocyte Ratio and Vitamin D Deficiency in Patients With Sickle Cell Disease: A Cross-Sectional Study in Central Uganda · 2026 · DOIThere is a need to investigate the association between NLR and vitamin D deficiency in SCD patients.
Association Between Neutrophil-to-Lymphocyte Ratio and Vitamin D Deficiency in Patients With Sickle Cell Disease: A Cross-Sectional Study in Central Uganda · 2026 · DOIThe aetiology of chronic pain in SCD is not well-defined. The traditional understanding of pain in SCD is limited to nociceptive and inflammatory models.
The Multifaceted Nature of Pain in Sickle Cell Disease: From Molecular Mechanisms to Emerging Therapeutic Frontiers · 2026 · DOILong-term endocrine outcomes remain limited. Conventional therapy is insufficient to prevent long-term endocrine morbidity. Incomplete hemoglobin normalization may limit downstream benefits.
Growth and Endocrine Preservation in Transfusion-Dependent β-Thalassemia: Updated Pharmacologic and Genomic Interventions · 2026 · DOIConventional therapy has limitations in preventing long-term endocrine morbidity. Long-term endocrine outcomes remain limited. There is a need for emerging therapies to improve growth and endocrine preservation.
Growth and Endocrine Preservation in Transfusion-Dependent β-Thalassemia: Updated Pharmacologic and Genomic Interventions · 2026 · DOILimited epidemiological data are available regarding hemoglobinopathies among non-tribal youth. There is a need for studies to investigate the burden of β-Thalassemia and Sickle Cell Disorders among non-tribal youth in Central Gujarat.
Burden of β-Thalassemia and Sickle Cell Disorders among Non-Tribal Youth in Central Gujarat: Evidence from a Population-Based HPLC Study · 2026 · DOIThere is a lack of research on oral radiographic changes in patients with severe sickle cell disease. The study aims to fill this gap by evaluating specific radiographic features in pediatric patients with SCD.
Oral Radiographic Changes in Severe Sickle Cell Anemia Patients: A Retrospective Comparative Study · 2026 · DOIThere is a need to investigate the relationship between anthropometric parameters and serum ferritin levels.
The patient had a documented hypersensitivity to deferasirox, limiting treatment options. The patient's iron burden could not be fully controlled due to the lack of effective chelation therapy.
Severe Thalassemia Bone Disease in a Young Woman with Transfusion-Dependent β-Thalassemia Major: Erlenmeyer Flask Deformity, Muscular Hemosiderin Deposition, and Profound Osteoporosis — A Case Report · 2026 · DOIThere is a need for new therapeutic alternatives to improve pain management in sickle cell anemia patients. Traditional therapies have limitations, and there is a gap in effective treatment options.
Neuromodulation: a new approach for chronic pain relief in patients with sickle cell anemia · 2026 · DOIThe need to evaluate D-dimer, fibrinogen levels and their correlation with platelets count in these patients.
EVALUATION OF D-DIMER, FIBRINOGEN LEVELS AND THEIR CORRELATION WITH PLATELETS COUNT IN Β-THALASSEMIA MAJOR PATIENTS · 2026 · DOIHydroxyurea (HU) remains the cornerstone of disease-modifying therapy, but its utilization, hematologic impact and relationship with disease severity among Nigerian children are not fully characterized.
Impact of hydroxyurea use on severity and hematologic profile in children with sickle cell disease at University of Benin Teaching Hospital, Benin city, Nigeria · 2026 · DOIPhysical challenges in managing children's needs. Emotional challenges in coping with the demands of caregiving. Social challenges in balancing caregiving responsibilities with other family and work obligations.
There is a lack of understanding of mothers' experiences in caring for children with thalassemia at home. Previous studies have focused on the medical aspects of thalassemia, with limited attention to the social and emotional impacts on families.
The study faces challenges in terms of data collection and analysis in resource-limited settings. The study has to deal with the lack of evidence on the real-world implementation and effectiveness of Hydroxyurea in resource-limited primary care settings. The study has to consider the potential biases and limitations of a retrospective cohort design.
Hydroxyurea treatment for sickle cell disease in Nairobi informal settlements: a retrospective cohort study · 2026 · DOIThe sample size was limited to 100 patients. The study was conducted in a single tertiary hospital, limiting generalizability. The study did not investigate delayed puberty and hormonal factors.
Limited treatment options due to hypersensitivity to deferasirox. Difficulty in controlling iron burden.
Severe Thalassemia Bone Disease in a Young Woman with Transfusion-Dependent β-Thalassemia Major: Erlenmeyer Flask Deformity, Muscular Hemosiderin Deposition, and Profound Osteoporosis — A Case Report · 2026 · DOISCD was strongly associated with a history of blood transfusion, family history of SCD, and low haemoglobin levels, while socio-demographic factors were not significant predictors. The findings confirm ongoing transmission of haemoglobinopathies in the study area.
High Burden of Sickle Cell Disease and Trait Among Young Children in Western Tanzania: Evidence from a Cross-Sectional Screening Study · 2026 · DOIBroader implications beyond SCD The therapeutic potential of targeting mitochondrial dysfunction in the red blood cells extends beyond SCD to other anemias, such as β−thalassemia, Diamond-Blackfan anemia (DBA), Systemic Lupus Erythematosus (SLE), and hereditary spherocytosis.
Evolving Insights into Mitochondrial Presence in RBC in Sickle Cell Disease: Red Blood Cell and Reticulocyte Pathophysiology, Therapeutic Strategies, and Future Directions · 2026 · DOIThere is a need to recognize and treat Hepatitis A infection early in children with sickle cell trait - There is a need to immunize children against Hepatitis…
Extreme Hyperbilirubinemia with Hepatitis – A Infection in a Child with Sickle Cell Trait · 2026 · DOIThe majority of patients depend on unrelated donors - Retaining donors and encouraging them to proceed with donation when matched is a major…
Most-cited papers in Hemoglobinopathies and Related Disorders
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia · Science · 1985 · 6,381 citations
- Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death · New England Journal of Medicine · 1994 · 2,615 citations
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia · New England Journal of Medicine · 1995 · 1,923 citations
- Sickle-cell disease · The Lancet · 2010 · 1,917 citations
- Management of Sickle Cell Disease · JAMA · 2014 · 1,418 citations
- Global epidemiology of haemoglobin disorders and derived service indicators · Bulletin of the World Health Organization · 2008 · 1,413 citations
- The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin · JAMA · 2005 · 1,370 citations
- Population Estimates of Sickle Cell Disease in the U.S. · American Journal of Preventive Medicine · 2010 · 1,051 citations
- Sickle Cell Disease in Africa · American Journal of Preventive Medicine · 2011 · 591 citations
- β-Thalassemias · New England Journal of Medicine · 2021 · 486 citations
Most recent work
- Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease · New England Journal of Medicine · 2026
- CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia · New England Journal of Medicine · 2026
- Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia · Blood · 2026
- Liver sinusoidal endothelial cells constitute a major route for hemoglobin clearance · EMBO Reports · 2026
- CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat Sickle Cell Disease · New England Journal of Medicine · 2026
- Human genetics implicates a BACH2-NRF2 axis in fetal hemoglobin activation · medRxiv · 2026
- Bone marrow transplantation for sickle cell disease using posttransplantation cyclophosphamide and 400 cGy TBI · Blood Advances · 2026
- Clinical outcomes of lentiviral vector gene therapy for sickle cell disease · Blood Advances · 2026
- Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease · New England Journal of Medicine · 2026
- Iron overload damages mitochondria and induces metabolic rewiring of hematopoietic stem cells toward glycolysis · Blood · 2026
Find a gap in your own Hemoglobinopathies and Related Disorders sub-topic
This page shows what the Hemoglobinopathies and Related Disorders literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →